Sézary Syndrome
📧 Sign up to get email alerts when something new happens for Sézary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients [Phase 2]
A Phase 2 trial update describes dosing of Brentuximab Vedotin for patients with Mycosis fungoides and Sézary syndrome, with lymphomatoid pa…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab in combination with gemcitabine in adults with advanced mycosis fungoides or Sézary s…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome [Phase 1]
A Phase 1 clinical trial evaluating Tulmimetostat (DZR123) in patients with mycosis fungoides and Sézary syndrome; the study is currently ac…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
A real-world study reports on the use of mogamulizumab for treating cutaneous T-cell lymphoma and its subtypes.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) [EARLY_Phase 1]
A first-in-human Phase 1 dose-escalation study of DT-7012, a CCR8-targeting monoclonal antibody from Domain Therapeutics, in relapsed or ref…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ritlecitinib in CTCL [Phase 2]
A Phase 2 trial of ritlecitinib for cutaneous T-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) [Phase 2]
Phase 2 trial evaluating maintenance treatment with resminostat in patients with advanced mycosis fungoides or Sézary syndrome has completed…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: VircapSeq Virus Detection in Sézary Syndrome
A completed study evaluated VircapSeq virus detection in patients with Sézary syndrome, a form of cutaneous T-cell lymphoma, with results po…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL [Phase 3]
Phase 3 clinical trial of naloxone hydrochloride for relief of pruritus in patients with cutaneous T-cell lymphoma (Mycosis Fungoides and Sé…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma [Phase 2]
Phase 2 trial updates the combination of pembrolizumab and interferon-gamma for various mycosis fungoides/Sezary syndrome and synovial sarco…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome [Phase 2]
Phase 2 trial update of lenalidomide in relapsed mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma) has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]
A Phase 2 trial evaluating alemtuzumab in relapsed or refractory advanced mycosis fungoides or Sézary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) [Phase 2]
Phase 2 trial update for NM-IL-12 in Cutaneous T-Cell Lymphoma undergoing total skin electron beam therapy (TSEBT).
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 1]
Phase 1 trial investigating gemcitabine and pemetrexed disodium in advanced mycosis fungoides or Sézary syndrome (a form of cutaneous T-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome [Phase 4]
Phase 4 trial evaluating neurokinin-1 receptor antagonism to treat pruritus in patients with Sézary syndrome; the study was terminated and r…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) [Phase 2]
A Phase 2 clinical trial evaluating oral vorinostat (SAHA) for advanced cutaneous T-cell lymphoma, including Sézary syndrome and mycosis fun…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma [Phase 2]
Phase 2 study update of the HDAC inhibitor quisinostat in previously treated Cutaneous T-Cell Lymphoma (Stage Ib-IVa) has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Effect of Denileukin Diftitox on Immune System in CTCL Patients
This completed trial update reports on the effects of denileukin diftitox on the immune system in patients with cutaneous T-cell lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Immunization Against Tumor Cells in Sezary Syndrome [Phase 2]
Status update indicates the completion of a Phase 2 clinical trial evaluating an immunization against tumor cells in Sézary syndrome (cutane…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome [Phase 3]
A Phase 3 trial evaluating an unspecified human monoclonal antibody for mycosis fungoides and Sézary syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome [Phase 2]
Phase 2 trial evaluating interleukin-2 in patients with Mycosis fungoides or Sézary syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome [Phase 2]
Phase 2 trial evaluating temozolomide for mycosis fungoides or Sézary syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome [Phase 2]
Phase 2 trial update examining tretinoin for treating mycosis fungoides and Sézary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients [Phase 4]
A Phase 4 clinical trial of ONTAK (denileukin diftitox) in cutaneous T-cell lymphoma patients (including mycosis fungoides and Sézary syndro…
-
CLINICAL_TRIALS trial_result · 2007-04-03Clinical Trial Update: Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating alemtuzumab for advanced mycosis fungoides and Sézary syndrome, with current status not specified.